A Randomized, Open-Label, Safety and Exploratory Efficacy Study of Kanglaite Injection (KLTi) plus Gemcitabine versus Gemcitabine in Patients with Advanced Pancreatic Cancer

Background: This study was designed to assess the safety and preliminary efficacy of KLTi plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer. Methods: In a randomized, open-label study, patients with locally advanced or metastatic pancreatic cancer were randomized 2:1...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartzberg, Lee S., Arena, Francis P., Bienvenu, Bryan J., Kaplan, Edward H., Camacho, Luis H., Campos, Luis T., Waymack, J. Paul, Tagliaferri, Mary A., Chen, Michael M., Li, Dapeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556651/
https://www.ncbi.nlm.nih.gov/pubmed/28819385
http://dx.doi.org/10.7150/jca.15407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556651/
https://www.ncbi.nlm.nih.gov/pubmed/28819385
http://dx.doi.org/10.7150/jca.15407

Ejemplares similares